[1]
|
Issekutz, K.A., Graham, Jr., J.M., Prasad, C., Smith, I.M. and Blake, K.D. (2005) An epidemiological analysis of CHARGE syndrome: Preliminary results from a Canadian study. American Journal of Medical Genetics Part A, 133, 309-317. doi:10.1002/ajmg.a.30560
|
[2]
|
Sanlaville, D. and Verloes, A. (2007) CHARGE syndrome: An update. European Journal of Medical Genetics, 15, 389-399.
|
[3]
|
Jongmans, M.C., Admiraal, R.J., Van Der Donk, K.P., Vissers, L.E., et al. (2006) CHARGE syndrome: The phenotypic spectrum of mutations in the CHD7 gene. Journal of Medical Genetics, 43, 306-314.
doi:10.1136/jmg.2005.036061
|
[4]
|
Zentner, G.E., Layman, W.S., Martin, D.M. and Scacheri, P.C. (2010) Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. American Journal of Medical Genetics Part A, 152, 674-686.
doi:10.1002/ajmg.a.33323
|
[5]
|
Vissers, L.E., Van Ravenswaaij, C.M., Admiraal, R., et al. (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nature Genetics, 36, 955-957. doi:10.1038/ng1407
|
[6]
|
Johnson, D.S., Morrison, N., Grant, L., et al. (2006) Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins. Journal of Medical Genetics, 43, 280-284.
doi:10.1136/jmg.2005.032946
|
[7]
|
Lalani, S.R., Safiullah, A.M., Fernbach, S.D., Harutyunyan, K.G., et al. (2006) Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. American Journal of Human Genetics, 78, 303-314. doi:10.1086/500273
|
[8]
|
Blake, K.D., Davenport, S.L., Hall, B.D., et al. (1998) CHARGE association: An update and review for the primary pediatrician. Clinical Pediatrics, 37, 159-173.
doi:10.1177/000992289803700302
|
[9]
|
Verloes, A. (2005) Updated diagnostic criteria for CHARGE syndrome: A proposal. American Journal of Medical Genetics Part A, 133, 306-308.
doi:10.1002/ajmg.a.30559
|
[10]
|
Sanlaville, D., Etchevers, H.C., Gonzales, M., Martinovic, J., Clément-Ziza, M., et al. (2006) Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. Journal of Medical Genetics, 43, 211-217. doi:10.1136/jmg.2005.036160
|
[11]
|
Ali, H. and Bahbahani, H. (2010) Umbilical cord blood stem cells—potential therapeutic tool for neural injuries and disorders. Acta Neurobiologiae Experimentalis, 70, 316-324.
|
[12]
|
Watt, S. and Contreras, M. (2005) Stem cell medicine: Umbilical cord blood and its stem cell potential. Seminars in Fetal and Neonatal Medicine, 10, 209-220.
doi:10.1016/j.siny.2005.02.001
|
[13]
|
Reimann, V., Creutzig, U. and Kogler, G. (2009) Stem cells derived from cord blood in transplantation and regenerative medicine. Deutsches Aerzteblatt international, 106, 831-836.
|
[14]
|
Verneris, M.R., Brunstein, C.G., Barker, J., Macmillan, M.L., Defor, T., McKenna, D.H., et al. (2009) Relapse risk after umbilical cord blood transplantation: Enhanced graft versus leukemia effect in recipients of tow units. Blood, 114, 4293-4299.
doi:10.1182/blood-2009-05-220525
|